碧迪医疗(Becton Dickinson)
BDX
191.75
-2.01
-1.04%
碧迪医疗(Becton Dickinson)
US · BDX
#450 按市值排名
上市于 1970
191.75
-2.01
-1.04%
实时 - 追踪5344个代码 - 心跳于495秒前
· 2026-10-16 19:30
最新新闻
-
Barclays Initiates Becton Dickinson & Co(BDX.US) With Sell Rating, Announces Target Price $165\u5e02\u573a\u8d44\u8baf · 2026/10/8
-
评级变动
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $208\u5e02\u573a\u8d44\u8baf · 2026/8/14
-
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $190\u5e02\u573a\u8d44\u8baf · 2026/10/3
-
Barclays Downgrades Becton Dickinson & Co(BDX.US) to Sell Rating, Cuts Target Price to $165\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
评级变动
Jefferies Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $210\u5e02\u573a\u8d44\u8baf · 2026/9/8
-
公司公告
Nippon Electric Glass: Developed a new product, "BDX-3," of the ultra-thin cover glass for space applications, Starveil.JPX · 2026/10/6
-
公司公告
GSH cb5.2%241012#: General Announcement-NOTICE OF REDEMPTION AND END OF CONVERSION PERIOD OF CONVERTIBLE BONDSSGX · 2024/6/25
-
评级变动
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $185\u5e02\u573a\u8d44\u8baf · 2026/8/11
-
公司公告
GSH cb5.2%241012#: Final Maturity-MandatorySGX · 2024/9/26
-
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $200\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
评级变动
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $182\u5e02\u573a\u8d44\u8baf · 2026/8/8
-
评级变动
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200\u5e02\u573a\u8d44\u8baf · 2026/8/31
-
评级变动
UBS Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $205\u5e02\u573a\u8d44\u8baf · 2026/8/12
-
评级变动
J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $188\u5e02\u573a\u8d44\u8baf · 2026/8/11
-
评级变动
Stifel Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $195\u5e02\u573a\u8d44\u8baf · 2026/8/13
-
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $208\u5e02\u573a\u8d44\u8baf · 2026/10/5
-
评级变动
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190\u5e02\u573a\u8d44\u8baf · 2026/8/13
-
公司公告
GSH cb5.2%241012#: Coupon Payment-MandatorySGX · 2024/9/20
-
公司公告
GSH cb5.2%241012#: General Announcement-Conversion and Cancellation of Convertible BondsSGX · 2024/8/28
-
评级变动
J.P. Morgan Remains a Hold on Becton Dickinson (BDX)TipRanks · 2026/8/11
-
评级变动
RBC Capital Initiates Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $180\u5e02\u573a\u8d44\u8baf · 2026/8/7
-
GSH Raises S$7.05 Million via SDAX Digital Securities IssuancesTipRanks · 2026/9/24
-
GSH Corp. Raises SG$18 Million Via Digital SecuritiesMT Newswires · 2026/9/25
-
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $208\u5e02\u573a\u8d44\u8baf · 2026/8/14
-
公司公告
GSH cb5.2%241012#: Notice of 3 Consecutive Years' Losses-Notice of 3 Consecutive Years' LossesSGX · 2024/4/9
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
碧迪医疗(Becton Dickinson) 讨论区 0 条评论